Encompass Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Encompass Health (EHC).

Price Target Range — 11 Quarters

Analyst Consensus — 11 Analysts

1S.Buy

10Buy

Consensus RatingBuy# Analysts11Avg. Consensus PT$130Upside to Avg. PT+1.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 10, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$125→$140
Aug 7, 2026	UBS	A.J. Rice	PT Raise	Buy	$150→$155
Aug 7, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$140→$150
Aug 6, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$140→$144
May 28, 2026	TD Cowen	Ryan Langston	Initiate	Buy	$125
May 5, 2026	Barclays	Andrew Mok	PT Cut	Overweight	$153→$140
Feb 6, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$150→$153
Oct 30, 2025	Barclays	Andrew Mok	PT Raise	Overweight	$141→$150
Oct 2, 2025	UBS	A.J. Rice	PT Raise	Buy	$140→$150
Sep 16, 2025	Keybanc	Matthew Gillmor	PT Raise	Overweight	$135→$140
Sep 10, 2025	B of A Securities	Kevin Fischbeck	PT Raise	Buy	$145→$160
Aug 14, 2025	Truist Securities	David Macdonald	PT Raise	Buy	$135→$140
Aug 6, 2025	UBS	Andrew Mok	PT Raise	Buy	$130→$140
Jun 5, 2025	Stephens & Co.	Raj Kumar	Maintained	Overweight	$135
May 27, 2025	Keybanc	Matthew Gillmor	PT Raise	Overweight	$122→$135
Apr 28, 2025	UBS	Andrew Mok	PT Raise	Buy	$117→$130
Apr 28, 2025	RBC Capital	Ben Hendrix	PT Raise	Outperform	$110→$125
Apr 28, 2025	Truist Securities	David Macdonald	PT Raise	Buy	$116→$135
Apr 25, 2025	Keybanc	Matthew Gillmor	PT Raise	Overweight	$120→$122
Apr 25, 2025	Barclays	Andrew Mok	PT Raise	Overweight	$118→$129

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

TD Cowen analyst Ryan Langston maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $125 to $140.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Encompass Health, Raises Price Target to $155

UBS analyst A.J. Rice maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $150 to $155.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $150

Truist Securities analyst David Macdonald maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $140 to $150.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $144

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $140 to $144.

Benzinga Newsdesk

PRO
TD Cowen Initiates Coverage On Encompass Health with Buy Rating, Announces Price Target of $125

TD Cowen analyst Ryan Langston initiates coverage on Encompass Health (NYSE:EHC) with a Buy rating and announces Price Target of $125.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Encompass Health, Lowers Price Target to $140

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and lowers the price target from $153 to $140.

Benzinga Newsdesk

Encompass Health Corp

Encompass Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

PRO
UBS Maintains Buy on Encompass Health, Raises Price Target to $155

PRO
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $150

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $144

PRO
TD Cowen Initiates Coverage On Encompass Health with Buy Rating, Announces Price Target of $125

PRO
Barclays Maintains Overweight on Encompass Health, Lowers Price Target to $140

People Also Watch

People Also Watch

Encompass Health Corp

Encompass Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

PROUBS Maintains Buy on Encompass Health, Raises Price Target to $155

PROTruist Securities Maintains Buy on Encompass Health, Raises Price Target to $150

PROBarclays Maintains Overweight on Encompass Health, Raises Price Target to $144

PROTD Cowen Initiates Coverage On Encompass Health with Buy Rating, Announces Price Target of $125

PROBarclays Maintains Overweight on Encompass Health, Lowers Price Target to $140

People Also Watch

People Also Watch

PRO
TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

PRO
UBS Maintains Buy on Encompass Health, Raises Price Target to $155

PRO
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $150

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $144

PRO
TD Cowen Initiates Coverage On Encompass Health with Buy Rating, Announces Price Target of $125

PRO
Barclays Maintains Overweight on Encompass Health, Lowers Price Target to $140